Abstract
This chapter starts with a short description of the principles of evidence-based medicine and how this contemporary approach to healthcare was corrupted by the pharmaceutical industry to serve its commercial interests. The main objective is to outline the conduct and dissemination of antidepressant trials. The author details the multiple methodological limitations of these studies and further explains how study results are selectively reported and misrepresented, often producing exaggerated efficacy and safety estimates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hengartner, M.P. (2022). Flaws in Antidepressant Research. In: Evidence-biased Antidepressant Prescription. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-82587-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-82587-4_4
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-030-82586-7
Online ISBN: 978-3-030-82587-4
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)